REFERENCES
- Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 1995; 13: 93–100.
- Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet 1994; 343: 251–4.
- Paulson DF. Impact of radical prostatectomy in the management of clinically localised disease. J Urol 1994; 152: 1826–30.
- Bagshaw MA, Cox RS, Hancock SL. Control of prostate cancer with radiotherapy: long-term results. J Urol 1994; 152: 1781–5.
- Adolfsson J, Steineck G, Hedlund PO. Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series. Urology 1997; 50: 722–6.
- Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330: 242–8.
- Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO. Fifteen-year survival in prostate cancer. JAMA 1997; 277: 467–71.
- Mellinger GT, Bailar JC, Arduino U. Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 1967; 124: 1011–7.
- Kirk D, Adib RS, Anderson JB, Ashken MH, Baumber CD, Bevis CRA, et al. Immediate vs deferred treatment for advanced prostate cancer. Br J Urol 1997; 79: 235–46.
- Lundgren R, Nordic 6, Josefsson KThe South Sweden Prostate Cancer Study Group. Immediate estrogen or estramustine phosphate therapy versus deferred endo-crine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. J Urol 1995; 153: 1580–6.
- Carlsson P. Varenhorst E. Screening for cancer of the prostate: a scientific dilemma. In: Szczepura A, Kankaanpää J, editors. Assessment of health care technologies: case studies, key concepts and strategic issues. New York: John Wiley & Sons, 1996: 157–76.
- Gilliland FD, Hunt WC, Key CR. Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era. Urology 1996; 48: 67–71.
- UICC (Union Internationale Contre le Cancer) TNM classification of malignant tumours. 4th ed. Geneva: Schweiz, International Union Against Cancer, 1992.
- World Health Organisation International histological classification of tumours: histological typing of prostate tumours. Geneva: World Health Organisation, 1980; No. 22.
- National Center for Health Statistics. Lunde AS. The person number system of Sweden, Norway, Denmark and Israel. Vital and health statistics. Series 2, No. 84. Washington, DC: Government Printing Office, 1980: DHHS 80–1358.
- Statistics-Health and Diseases. Cancer incidence in Sweden 1996. The National Board of Health and Welfare, Centre for Epidemiology. Stockholm: Nor-stedts Tryckeri AB, 1998.
- Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical prostatec-tomy: results at 10 years. J Urol 1994; 152: 1831–6.